Publications by authors named "Ronald D Perrone"

Claim this Profile
A
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure.
Hiddo J L Heerspink, Willem H Collier, Juhi Chaudhari, Shiyuan Miao, Hocine Tighiouart, Ronald D Perrone

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualitative Analysis and Comparison of Externally Led Patient-Focused Drug Development Concepts for Autosomal Recessive Polycystic Kidney Disease Against SONG Initiatives.
Belle Soyfer, Sorin Fedeles, Wendy Ruyle, Elise Hoover, Max C Liebau, Ronald D Perrone

Kidney Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2025.
Craig E Gordon, Pranav S Garimella, Ronald D Perrone, Dana C Miskulin

Am J Kidney Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the Cystic Phenotype Associated with Monoallelic ALG8 and ALG9 Pathogenic Variants.
Tabinda Jawaid, Doaa E Elbarougy, Sravanthi Lavu, Guillaume Buia, Sarah R Senum, Ronald D Perrone

J Am Soc Nephrol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Implications of Slope of GFR in Clinical Trials of CKD Progression.
Tom Greene, Willem Collier, Benjamin Haaland, Chong Zhang, Sunil V Badve, Ronald D Perrone

Clin J Am Soc Nephrol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease in US Clinical Practice With Comparison to Historical Control Data.
Ronald D Perrone, Diana Garbinsky, Sasikiran Nunna, Hema K Gandhi, Ancilla W Fernandes

Kidney Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing Meaningful Patient-Centered Outcomes with Relevance for Patients with Polycystic Kidney Disease: Patient, Caregiver, and Researcher Priorities for Research in Polycystic Kidney Disease.
Reem A Mustafa, Hassan Kawtharany, Mohamad A Kalot, Crystal Y Lumpkins, Kim S Kimminau, Ronald D Perrone

Kidney360· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary.
Vicente E Torres, Curie Ahn, Thijs R M Barten, Godela Brosnahan, Melissa A Cadnapaphornchai, Ronald D Perrone

Kidney Int· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validating the SONG-PKD Pain Instrument, a Core Outcome Measure for Pain in ADPKD.
Rosanna Cazzolli, Angela Ju, Patrizia Natale, Armando Teixeira-Pinto, Martin Howell, Ronald D Perrone

Kidney Int Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Dual RAAS Blockade and Intensive BP Lowering on Risk of End-Stage Kidney Disease and Death in Autosomal Dominant Polycystic Kidney Disease: Long-term Follow-up of the HALT-PKD Trials.
Elaine Ku, Timothy P Copeland, Charles E McCulloch, Kaleab Z Abebe, Michel Chonchol, Ronald D Perrone

Am J Kidney Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mission and Future Plans for the Autosomal Dominant Polycystic Kidney Disease Centers of Excellence Program.
Elise Hoover, Heidi Cambareri, Arlene B Chapman, Fouad T Chebib, Savanna Moore, Ronald D Perrone

Kidney360· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A meta-analysis of randomized controlled clinical trials for implications of acute treatment effects on glomerular filtration rate for long-term kidney protection.
Hiddo J L Heerspink, Devin Eddington, Juhi Chaudhari, Raymond Estacio, Enyu Imai, Ronald D Perrone

Kidney Int· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry.
Elise Hoover, Vanessa Holliday, Nicole Merullo, Dorothee Oberdhan, Ronald D Perrone

Kidney Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Effects of Tolvaptan and Instruction to Increase Water Consumption in ADPKD: Post Hoc Analysis of TEMPO 3:4.
Joga Gobburu, Vijay Ivaturi, Xiaofeng Wang, Susan E Shoaf, Pravin Jadhav, Ronald D Perrone

Kidney360· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure.
Lesley A Inker, Willem Collier, Tom Greene, Shiyuan Miao, Juhi Chaudhari, Ronald D Perrone

Nat Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD.
Hiddo J L Heerspink, Lesley A Inker, Hocine Tighiouart, Willem H Collier, Benjamin Haaland, Ronald D Perrone

J Am Soc Nephrol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial.
Ronald T Gansevoort, Ali Hariri, Pascal Minini, Curie Ahn, Arlene B Chapman, Ronald D Perrone

Am J Kidney Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges.
Fouad T Chebib, Ronald D Perrone

Adv Kidney Dis Health· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD.
Ronald D Perrone, Dorothee Oberdhan, John Ouyang, Daniel G Bichet, Klemens Budde

Kidney Int Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Is Autosomal Dominant Polycystic Kidney Disease?
Ahsan Alam, Emilie Cornec-Le Gall, Ronald D Perrone

JAMA· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Longitudinal Urinary Metabolic Biomarkers With ADPKD Severity and Response to Metformin in TAME-PKD Clinical Trial Participants.
Kenneth R Hallows, Kaleab Z Abebe, Hui Li, Biagio Saitta, Andrew D Althouse, Ronald D Perrone

Kidney Int Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD.
Willem Collier, Lesley A Inker, Benjamin Haaland, Gerald B Appel, Sunil V Badve, Ronald D Perrone

Clin J Am Soc Nephrol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Patient-Reported Outcomes Tool to Assess Pain and Discomfort in Autosomal Dominant Polycystic Kidney Disease.
Dorothee Oberdhan, Jason C Cole, Mark J Atkinson, Holly B Krasa, Sara N Davison, Ronald D Perrone

Clin J Am Soc Nephrol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKD.
Ronald D Perrone, Ali Hariri, Pascal Minini, Curie Ahn, Arlene B Chapman

Kidney Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Basic Characteristics of a National Patient-Powered Registry in ADPKD.
Elise Hoover, Ronald D Perrone, Chris Rusconi, Beverly Benson, Neera K Dahl

Kidney360· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis